Basit öğe kaydını göster

dc.contributor.authorOrfanos, CE
dc.contributor.authorDaniel, P
dc.contributor.authorEberle, J
dc.contributor.authorGeilen, CC
dc.contributor.authorRaisova, M
dc.contributor.authorBEKTAŞ, Muhammet
dc.contributor.authorWieder, T
dc.date.accessioned2022-02-18T09:33:20Z
dc.date.available2022-02-18T09:33:20Z
dc.date.issued2000
dc.identifier.citationRaisova M., BEKTAŞ M., Wieder T., Daniel P., Eberle J., Orfanos C., Geilen C., "Resistance to CD95/Fas-induced and ceramide-mediated apoptosis of human melanoma cells is caused by a defective mitochondrial cytochrome c release", FEBS LETTERS, cilt.473, sa.1, ss.27-32, 2000
dc.identifier.issn1873-3468
dc.identifier.othervv_1032021
dc.identifier.otherav_45a83158-a109-45bc-8d2c-82cdeb4e0acf
dc.identifier.urihttp://hdl.handle.net/20.500.12627/177435
dc.identifier.urihttps://doi.org/10.1016/s0014-5793(00)01491-5
dc.description.abstractIntracellular CD95/Fas-signaling pathways have not been investigated in melanoma yet, Two different CD95 receptor-induced apoptotic pathways are presently known in other cell types: (i) direct activation of caspase-8 and (ii) induction of ceramide-mediated mitochondrial activation, both leading to subsequent caspase-3 activation. In the present study, five of II melanoma cell populations were shown to release cytochrome c from mitochondria, which activates caspase-3 and finally results in DNA fragmentation upon treatment with the agonistic monoclonal antibody CH-11. In contrast, this apoptotic pathway was not activated in the remaining six melanoma cell populations, interestingly, the susceptibility of melanoma cells to CD95L/FasL-triggered cell death was clearly correlated with N-acetylsphingosine-mediated apoptosis, Our results are in line with a defect upstream of mitochondrial cytochrome c release in resistant cells. (C) 2000 Federation of European Biochemical Societies.
dc.language.isoeng
dc.subjectCancer Research
dc.subjectMolecular Biology
dc.subjectDrug Discovery
dc.subjectAging
dc.subjectHealth Sciences
dc.subjectBiochemistry
dc.subjectBiophysics
dc.subjectStructural Biology
dc.subjectBiochemistry (medical)
dc.subjectLife Sciences
dc.subjectGeneral Biochemistry, Genetics and Molecular Biology
dc.subjectBİYOKİMYA VE MOLEKÜLER BİYOLOJİ
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectBİYOFİZİK
dc.subjectBiyoloji ve Biyokimya
dc.subjectHÜCRE BİYOLOJİSİ
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectBiyofizik
dc.subjectBiyokimya
dc.subjectHistoloji-Embriyoloji
dc.subjectYaşam Bilimleri
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectSitogenetik
dc.subjectTemel Bilimler
dc.subjectBiochemistry, Genetics and Molecular Biology (miscellaneous)
dc.subjectClinical Biochemistry
dc.subjectCell Biology
dc.titleResistance to CD95/Fas-induced and ceramide-mediated apoptosis of human melanoma cells is caused by a defective mitochondrial cytochrome c release
dc.typeMakale
dc.relation.journalFEBS LETTERS
dc.contributor.department, ,
dc.identifier.volume473
dc.identifier.issue1
dc.identifier.startpage27
dc.identifier.endpage32
dc.contributor.firstauthorID3371818


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster